About Index Trending news
Analyze
Top 50 Pricing
Prosensa

Prosensa

Work at Prosensa? Add yourself to this profile

Prosensa

We aim to develop innovative, RNA-modulating therapeutics to address unmet medical needs for patients with rare genetic diseases

Elsewhere

Alexa global traffic share

Latest funding Show all
Grant
$200,000
Venture capital
$29,766,600
Locations
HQ

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Prosensa makes some noise.